MYOS RENS Technology Stock Price, News & Analysis (NASDAQ:MYOS)

$1.31 -0.01 (-0.76 %)
(As of 02/20/2018 02:42 AM ET)
Previous Close$1.32
Today's Range$1.28 - $1.33
52-Week Range$1.03 - $3.93
Volume14,600 shs
Average Volume146,985 shs
Market Capitalization$8.31 million
P/E Ratio-1.98
Dividend YieldN/A
Beta0.41

About MYOS RENS Technology (NASDAQ:MYOS)

MYOS RENS Technology Inc. (MYOS), formerly MYOS Corporation, is an early-stage bionutrition and biotherapeutics company. The Company is focused on the discovery, development and commercialization of products that improve muscle health and function essential for the management of sarcopenia, cachexia and degenerative muscle diseases, and as an adjunct to the treatment of obesity. The Company is focused on the discovery, development, and commercialization of nutritional supplements, functional foods, therapeutic products, and other technologies for maintaining the health and performance of muscle tissue. MYOS is evaluating the modulation of myostatin. Its research is focused on developing strategies and therapeutic interventions to address muscle related conditions, including sarcopenia, cachexia, and inherited and acquired muscle diseases. The Company, through its subsidiary, holds the intellectual property pertaining to Fortetropin, which is a dietary supplement.

Receive MYOS News and Ratings via Email

Sign-up to receive the latest news and ratings for MYOS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Special Foods & Welbeing Products
Sub-IndustryN/A
SectorNon-Cyclical Consumer Goods & Services
SymbolNASDAQ:MYOS
CUSIPN/A
Phone+1-973-5090444

Debt

Debt-to-Equity RatioN/A
Current Ratio5.92%
Quick Ratio2.12%

Price-To-Earnings

Trailing P/E Ratio-1.98484848484848
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$330,000.00
Price / Sales25.17
Cash FlowN/A
Price / CashN/A
Book Value$1.04 per share
Price / Book1.26

Profitability

Trailing EPS($0.66)
Net Income$-4,340,000.00
Net Margins-941.41%
Return on Equity-71.14%
Return on Assets-65.15%

Miscellaneous

Employees9
Outstanding Shares6,340,000

MYOS RENS Technology (NASDAQ:MYOS) Frequently Asked Questions

What is MYOS RENS Technology's stock symbol?

MYOS RENS Technology trades on the NASDAQ under the ticker symbol "MYOS."

How were MYOS RENS Technology's earnings last quarter?

MYOS RENS Technology Inc (NASDAQ:MYOS) posted its quarterly earnings data on Tuesday, November, 14th. The company reported ($0.13) EPS for the quarter. The firm earned $0.16 million during the quarter. MYOS RENS Technology had a negative return on equity of 71.14% and a negative net margin of 941.41%. View MYOS RENS Technology's Earnings History.

When will MYOS RENS Technology make its next earnings announcement?

MYOS RENS Technology is scheduled to release their next quarterly earnings announcement on Thursday, March, 29th 2018. View Earnings Estimates for MYOS RENS Technology.

Who are some of MYOS RENS Technology's key competitors?

Who are MYOS RENS Technology's key executives?

MYOS RENS Technology's management team includes the folowing people:

  • Robert J. Hariri M.D. Ph.D., Independent Chairman of the Board (Age 58)
  • Joseph Mannello, Chief Executive Officer (Age 59)
  • Victor E. Mandel, Director (Age 51)
  • Christopher R. Pechock, Director (Age 51)
  • Bin Zhou, Director (Age 37)
  • Louis J. Aronne, Independent Director (Age 60)
  • Ren Ren, Independent Director Global Chairman (Age 54)

How do I buy MYOS RENS Technology stock?

Shares of MYOS RENS Technology can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is MYOS RENS Technology's stock price today?

One share of MYOS RENS Technology stock can currently be purchased for approximately $1.31.

How big of a company is MYOS RENS Technology?

MYOS RENS Technology has a market capitalization of $8.31 million and generates $330,000.00 in revenue each year. The company earns $-4,340,000.00 in net income (profit) each year or ($0.66) on an earnings per share basis. MYOS RENS Technology employs 9 workers across the globe.

How can I contact MYOS RENS Technology?

MYOS RENS Technology's mailing address is 45 Horsehill Rd Ste 106, CEDAR KNOLLS, NJ 07927-2009, United States. The company can be reached via phone at +1-973-5090444 or via email at [email protected]


MarketBeat Community Rating for MYOS RENS Technology (MYOS)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  39 (Vote Outperform)
Underperform Votes:  38 (Vote Underperform)
Total Votes:  77
MarketBeat's community ratings are surveys of what our community members think about MYOS RENS Technology and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

MYOS RENS Technology (NASDAQ:MYOS) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

MYOS RENS Technology (NASDAQ:MYOS) Earnings History and Estimates Chart

Earnings by Quarter for MYOS RENS Technology (NASDAQ:MYOS)

MYOS RENS Technology (NASDAQ MYOS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/29/2018N/AView Earnings Details
11/14/2017Q3 2017($0.13)$0.16 millionViewN/AView Earnings Details
8/14/2017Q2 2017($0.19)$0.06 millionViewN/AView Earnings Details
5/12/2017Q1 2017($0.20)$0.15 millionViewN/AView Earnings Details
3/30/2017Q4 2016($0.14)$0.03 millionViewN/AView Earnings Details
11/14/2016Q3 2016($0.17)$0.04 millionViewN/AView Earnings Details
8/12/2016Q2 2016($0.30)$0.07 millionViewN/AView Earnings Details
5/13/2016Q1 2016($0.31)$0.20 millionViewN/AView Earnings Details
5/14/2015Q1 2015($0.50)$0.01 millionViewN/AView Earnings Details
11/14/2014Q3 2014($0.24)($0.73)$1.90 million$0.11 millionViewN/AView Earnings Details
8/14/2014Q214($0.20)($0.32)$1.70 million$1.68 millionViewN/AView Earnings Details
5/16/2014Q1 2014($0.16)$1.55 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

MYOS RENS Technology (NASDAQ:MYOS) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for MYOS RENS Technology (NASDAQ:MYOS)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

MYOS RENS Technology (NASDAQ MYOS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 45.70%
Institutional Ownership Percentage: 2.74%
Insider Trades by Quarter for MYOS RENS Technology (NASDAQ:MYOS)

MYOS RENS Technology (NASDAQ MYOS) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/21/2017Joseph MannelloCEOBuy20,336$1.46$29,690.56274,765View SEC Filing  
12/8/2017Joseph MannelloCEOBuy38,119$1.35$51,460.65233,629View SEC Filing  
12/6/2017Joseph MannelloCEOBuy16,819$1.35$22,705.65233,629View SEC Filing  
11/16/2017Joseph MannelloCEOBuy25,000$1.31$32,750.00203,560View SEC Filing  
11/14/2017Joseph MannelloCEOBuy11,750$1.27$14,922.50203,560View SEC Filing  
9/23/2016Zhengguang LyuDirectorBuy50,000$1.70$85,000.0083,505View SEC Filing  
9/6/2016Zhengguang LyuDirectorBuy23,505$1.60$37,608.0010,600View SEC Filing  
6/17/2016Zhengguang LyuDirectorBuy10,000$1.65$16,500.0010,000View SEC Filing  
4/8/2016Joseph MannelloDirectorBuy4,417$1.96$8,657.32177,879View SEC Filing  
4/5/2016Joseph MannelloDirectorBuy6,128$1.75$10,724.00170,962View SEC Filing  
9/29/2015Robert J. HaririDirectorBuy2,300$2.68$6,164.0092,364View SEC Filing  
9/25/2015Robert J. HaririDirectorBuy12,150$2.44$29,646.0090,064View SEC Filing  
9/11/2015Robert J. HaririDirectorBuy4,000$1.73$6,920.0077,914View SEC Filing  
9/8/2015Robert J. HaririDirectorBuy25,250$1.71$43,177.5073,914View SEC Filing  
9/4/2015Louis J AronneDirectorBuy5,000$1.76$8,800.0022,200View SEC Filing  
8/28/2015Robert J HaririDirectorBuy2,750$1.74$4,785.0048,664View SEC Filing  
12/4/2014Robert J HaririDirectorBuy2,200$8.16$17,952.00View SEC Filing  
8/18/2014Peter DiamandisDirectorBuy3,444$14.51$49,972.44View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

MYOS RENS Technology (NASDAQ MYOS) News Headlines

Source:
DateHeadline
MYOS RENS Technology to Showcase Fortetropin® and the Qurr® Line of Muscle Health Products at the 2018 Arnold Sports Festival in Columbus, OH from March 2-4, 2018MYOS RENS Technology to Showcase Fortetropin® and the Qurr® Line of Muscle Health Products at the 2018 Arnold Sports Festival in Columbus, OH from March 2-4, 2018
finance.yahoo.com - February 15 at 8:56 AM
MYOS RENS Technology (MYOS) Upgraded by ValuEngine to "Sell"MYOS RENS Technology (MYOS) Upgraded by ValuEngine to "Sell"
www.americanbankingnews.com - February 4 at 9:14 PM
MYOS RENS Technology Launches 30-Day Qurr® Fortetropin® ChallengeMYOS RENS Technology Launches 30-Day Qurr® Fortetropin® Challenge
www.prnewswire.com - January 16 at 6:24 AM
MYOS RENS Technology CEO Issues Shareholder LetterMYOS RENS Technology CEO Issues Shareholder Letter
finance.yahoo.com - January 11 at 9:52 AM
Insider Buying: MYOS RENS Technology Inc (MYOS) CEO Purchases 20,336 Shares of StockInsider Buying: MYOS RENS Technology Inc (MYOS) CEO Purchases 20,336 Shares of Stock
www.americanbankingnews.com - December 26 at 6:20 PM
Insider Buying: MYOS RENS Technology Inc. (MYOS) CEO Buys 16,819 Shares of StockInsider Buying: MYOS RENS Technology Inc. (MYOS) CEO Buys 16,819 Shares of Stock
www.americanbankingnews.com - December 8 at 11:16 PM
Insider Buying: MYOS RENS Technology Inc. (MYOS) CEO Buys 38,119 Shares of StockInsider Buying: MYOS RENS Technology Inc. (MYOS) CEO Buys 38,119 Shares of Stock
www.americanbankingnews.com - December 8 at 8:52 PM
MYOS RENS Technology Enters Into Research Agreement With University Of California, Berkeley To Study Effects Of Fortetropin® On Skeletal Muscle Protein Synthetic Rate In Older Men And WomenMYOS RENS Technology Enters Into Research Agreement With University Of California, Berkeley To Study Effects Of Fortetropin® On Skeletal Muscle Protein Synthetic Rate In Older Men And Women
finance.yahoo.com - December 6 at 9:42 AM
MYOS RENS Technology Inc. (MYOS) CEO Acquires $14,922.50 in StockMYOS RENS Technology Inc. (MYOS) CEO Acquires $14,922.50 in Stock
www.americanbankingnews.com - November 16 at 9:44 PM
MYOS RENS Technology Inc. (MYOS) CEO Acquires $32,750.00 in StockMYOS RENS Technology Inc. (MYOS) CEO Acquires $32,750.00 in Stock
www.americanbankingnews.com - November 16 at 9:24 PM
MYOS RENS Technology Inc. (MYOS) Releases  Earnings ResultsMYOS RENS Technology Inc. (MYOS) Releases Earnings Results
www.americanbankingnews.com - November 15 at 1:05 PM
MYOS RENS Technology Reports Third Quarter 2017 Financial ResultsMYOS RENS Technology Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 15 at 6:38 AM
MYOS RENS Technology Inc. Launches Collegiate Sports Marketing PlatformMYOS RENS Technology Inc. Launches Collegiate Sports Marketing Platform
finance.yahoo.com - November 9 at 6:46 AM
Who Really Owns MYOS RENS Technology Inc (MYOS)?Who Really Owns MYOS RENS Technology Inc (MYOS)?
finance.yahoo.com - November 4 at 6:53 AM
An Initiative To Promote Muscle Health And Its Importance In Fighting Aging And Speeding Up Post Workout RecoveryAn Initiative To Promote Muscle Health And Its Importance In Fighting Aging And Speeding Up Post Workout Recovery
globenewswire.com - October 27 at 8:16 AM
Pro Football Legends, the Commercial Marketing Arm of the NFL Alumni, Launches Partnership with MYOS RENS Technology Inc. in Optimal Bowl and Wellness ChallengePro Football Legends, the Commercial Marketing Arm of the NFL Alumni, Launches Partnership with MYOS RENS Technology Inc. in Optimal Bowl and Wellness Challenge
finance.yahoo.com - October 27 at 8:16 AM
BRIEF-Myos Rens Technology Inc appoints Joseph Mannello as permanent CEOBRIEF-Myos Rens Technology Inc appoints Joseph Mannello as permanent CEO
www.reuters.com - September 22 at 10:00 AM
MYOS RENS Technology Inc. Appoints Joseph Mannello as Permanent Chief Executive OfficerMYOS RENS Technology Inc. Appoints Joseph Mannello as Permanent Chief Executive Officer
finance.yahoo.com - September 22 at 10:00 AM
MYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017MYOS RENS Technology, Inc. :MYOS-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017
finance.yahoo.com - August 25 at 8:58 AM
MYOS RENS to Introduce the Qurr® Line of Muscle Health Products at 35th IDEA World Convention July 19-23, 2017 in Las VegasMYOS RENS to Introduce the Qurr® Line of Muscle Health Products at 35th IDEA World Convention July 19-23, 2017 in Las Vegas
finance.yahoo.com - July 13 at 7:06 AM
How These Generic Drugs Stocks are Faring? -- MYOS RENS Technology, Akari Therapeutics, Flexion Therapeutics, and Zynerba PharmaHow These Generic Drugs Stocks are Faring? -- MYOS RENS Technology, Akari Therapeutics, Flexion Therapeutics, and Zynerba Pharma
www.prnewswire.com - May 19 at 7:13 PM
MYOS RENS Technology to host April 4 interactive conference call on "Qurr" product launchMYOS RENS Technology to host April 4 interactive conference call on "Qurr" product launch
us.rd.yahoo.com - March 31 at 9:26 AM
MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExMYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex
biz.yahoo.com - February 21 at 6:13 PM
MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to RiMYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Ri
us.rd.yahoo.com - February 15 at 2:17 AM
MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, FMYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, F
biz.yahoo.com - February 8 at 7:36 PM
2:55 pm MYOS RENS Tech. commences $2.125 common stock offering; to sell 500k shares at $4.25/share2:55 pm MYOS RENS Tech. commences $2.125 common stock offering; to sell 500k shares at $4.25/share
us.rd.yahoo.com - February 4 at 5:31 AM
MYOS RENS TECHNOLOGY INCMYOS RENS TECHNOLOGY INC
www.finanznachrichten.de - February 4 at 12:30 AM
MYOS RENS Tech (MYOS) Reports $2.13M Registered Direct Offering of Common StockMYOS RENS Tech (MYOS) Reports $2.13M Registered Direct Offering of Common Stock
www.streetinsider.com - February 3 at 7:28 PM
MYOS RENS Technology Inc. Announces $2,125,000 Registered Direct OfferingMYOS RENS Technology Inc. Announces $2,125,000 Registered Direct Offering
www.marketwatch.com - February 3 at 7:28 PM
MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, OtherMYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other
biz.yahoo.com - January 11 at 7:21 PM
MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersMYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - December 22 at 7:02 PM
MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive AgreementMYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
biz.yahoo.com - November 25 at 11:34 AM
BRIEF-Myos Rens Technology appoints Joseph Mannello interim CEOBRIEF-Myos Rens Technology appoints Joseph Mannello interim CEO
www.reuters.com - August 31 at 11:21 AM
MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other EventsMYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events
biz.yahoo.com - August 24 at 6:07 PM
MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Change in Directors or Principal OfficersMYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Change in Directors or Principal Officers
biz.yahoo.com - June 29 at 4:17 PM
MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Changes in Registrants Certifying AccountantMYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant
biz.yahoo.com - May 20 at 5:26 PM
MYOS RENS TECHNOLOGY INC. Files SEC form 10-Q, Quarterly ReportMYOS RENS TECHNOLOGY INC. Files SEC form 10-Q, Quarterly Report
biz.yahoo.com - May 13 at 8:34 AM
MYOS RENS TECHNOLOGY INC. Files SEC form 10-K, Annual ReportMYOS RENS TECHNOLOGY INC. Files SEC form 10-K, Annual Report
biz.yahoo.com - March 30 at 5:53 PM
MYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, FinancMYOS RENS TECHNOLOGY INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financ
biz.yahoo.com - March 22 at 4:33 PM
MYOS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, ChaMYOS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Cha
biz.yahoo.com - March 8 at 5:31 PM
MYOS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other EventsMYOS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other Events
biz.yahoo.com - February 4 at 5:21 PM

SEC Filings

MYOS RENS Technology (NASDAQ:MYOS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

MYOS RENS Technology (NASDAQ:MYOS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

MYOS RENS Technology (NASDAQ MYOS) Stock Chart for Tuesday, February, 20, 2018

Loading chart…

This page was last updated on 2/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.